))
Managing Ocular Side Effects in ELAHERE Treatment
Manage episode 444705669 series 3599769
Content provided by Ontada Learn. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Ontada Learn or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
In this episode, Dr. Kristen Lamoreau, OD, delves into the critical role eye care professionals play in managing ocular adverse events for patients undergoing treatment with ELAHERE, the first and only antibody-drug conjugate targeting folate receptor alpha (FRα). As a groundbreaking treatment for certain types of resistant ovarian cancer, ELAHERE is associated with ocular toxicities, necessitating a collaborative approach between eye care providers and oncology teams.
13 episodes
Share
